No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
HIMS Downgraded, Agilon Upgraded at Citi in 2025 Health Tech Review
Citi Upgrades Agilon Health(AGL.US) to Hold Rating, Raises Target Price to $2.25
Needham Reiterates Hold on Agilon Healthto Hold
Express News | Agilon Health Inc : Citigroup Raises to Neutral From Sell; Raises Target Price to $2.25 From $1.75
Goldman Sachs Maintains Agilon Health(AGL.US) With Hold Rating, Announces Target Price $2.5
Worst Performing Stocks for Tax Loss Selling – Wolfe